William Blair Elevates Repligen Earnings Forecasts: What Investors Need to Know
Repligen Corporation, a leading biotechnology firm, is once again in the financial spotlight as William Blair analysts have recently revised their earnings per share estimates upward, signaling…
Harvest Fund Management Invests $132K in Repligen Corporation (RGEN)
Harvest Fund Management Co. Ltd has made a notable move in the financial markets, acquiring a significant new stake in Repligen Corporation, a leading biotechnology firm traded…
Analysts Issue ‘Moderate Buy’ Consensus for Repligen (RGEN) Stock: What It Means
Repligen Corporation (NASDAQ:RGEN), a key player in the biotechnology sector, has recently garnered a consensus rating of “Moderate Buy” from leading brokerage firms, as reported by MarketBeat.com….